GLPG Galapagos NV ADRs

Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions. This is an ADR of a company whose stock trades outside of the U.S. as the symbol NA:GLPG.

$51.75  -0.75 (-1.43%)
As of 10/27/2021 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Belgium
Country of incorporation:  Belgium
IPO date:  07/07/2008
Outstanding shares:  65,530,121
Average volume:  208,739
Market cap:   $3,378,077,738
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    36315X101
ISIN:        US36315X1019
Sedol:      B292NQ7
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.29
PS ratio:   5.49
Return on equity:   -7.31%
Net income %:   -36.75%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy